Our study is helpful in understanding the mechanisms by which cisplatin kills lung cancer cells and provides further compelling evidence that IRF-1 is involved in the anti-cancer effect of cisplatin by promoting apoptosis and inhibiting autophagy to disturb mitochondrial homeostasis (Fig. 8). The gene discussed is IRF1; the disease is lung carcinoma.